Lampard (Colecalciferol)

Colecalciferol is converted first in the liver to 25‑hydroxyvitamin D and then in the kidney to the active hormone 1,25‑dihydroxyvitamin D. This active form binds to vitamin D receptors in the intestine, increasing the synthesis of calcium‑binding proteins and enhancing calcium and phosphate absorption, which are essential for healthy bone formation.

The appropriate dose of Lampard is determined by a prescriber based on the individual’s serum vitamin D level, age, weight, and clinical condition. Healthcare professionals tailor the regimen to achieve optimal vitamin D status while minimizing the risk of excess calcium.

Safety data for colecalciferol in pregnancy and lactation are limited. Women who are pregnant or breastfeeding should discuss use with their healthcare provider, who will weigh potential benefits against any uncertain risks before recommending the supplement.

To order Lampard, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lampard provides colecalciferol, the same vitamin D3 form found in most oral supplements. Compared with vitamin D2 (ergocalciferol), vitamin D3 has a longer half‑life and is generally considered more effective at raising and maintaining serum 25‑hydroxyvitamin D concentrations.

Store Lampard at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Lampard is taken orally, usually with or without food, as directed by a healthcare professional. The tablet or capsule should be swallowed whole with a glass of water unless otherwise instructed.

The most serious risk is hypercalcemia, which can lead to kidney stones, cardiac arrhythmias, or soft‑tissue calcification. Signs include excessive thirst, frequent urination, nausea, and muscle weakness. If these symptoms occur, discontinue use and seek medical attention promptly.

Individuals with known hypersensitivity to colecalciferol or any excipients in the product should avoid Lampard. Patients with severe hypercalcemia, hypervitaminosis D, or certain granulomatous diseases should not use it without close medical supervision.